Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-406079
Filing Date
2014-11-10
Accepted
2014-11-10 16:21:27
Documents
15
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d794171d10q.htm 10-Q 597488
2 EX-10.1 d794171dex101.htm EX-10.1 13389
3 EX-31.1 d794171dex311.htm EX-31.1 8584
4 EX-31.2 d794171dex312.htm EX-31.2 8623
5 EX-32.1 d794171dex321.htm EX-32.1 3126
6 EX-32.2 d794171dex322.htm EX-32.2 3132
13 GRAPHIC g794171g64z30.jpg GRAPHIC 7196
14 GRAPHIC g794171g87f19.jpg GRAPHIC 12520
15 GRAPHIC g794171g90r61.jpg GRAPHIC 9345
  Complete submission text file 0001193125-14-406079.txt   4090454

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ttph-20140930.xml EX-101.INS 482446
8 XBRL TAXONOMY EXTENSION SCHEMA ttph-20140930.xsd EX-101.SCH 39339
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttph-20140930_cal.xml EX-101.CAL 50958
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttph-20140930_def.xml EX-101.DEF 113075
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttph-20140930_lab.xml EX-101.LAB 340129
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttph-20140930_pre.xml EX-101.PRE 231321
Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Filer) CIK: 0001373707 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35837 | Film No.: 141208938
SIC: 2834 Pharmaceutical Preparations